Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy[S]
暂无分享,去创建一个
S. Scherer | J. Belmont | R. Hegele | C. Ballantyne | S. Virani | M. Barbalić | A. Brautbar | Fengju Chen
暂无分享,去创建一个
S. Scherer | J. Belmont | R. Hegele | C. Ballantyne | S. Virani | M. Barbalić | A. Brautbar | Fengju Chen